Blood pressure levels and mortality risk among hemodialysis patients in the Dialysis Outcomes and Practice Patterns Study

肾脏疾病 腹膜透析 危险系数 肾脏替代疗法 急诊医学 肾病科 风险因素 人口 肾功能 优势比
作者
Bruce M. Robinson,Lin Tong,Jinyao Zhang,Robert A. Wolfe,David A. Goodkin,Roger Greenwood,Peter G. Kerr,Hal Morgenstern,Yun Li,Ronald L. Pisoni,Rajiv Saran,Francesca Tentori,Tadao Akizawa,Shunichi Fukuhara,Friedrich K. Port
出处
期刊:Kidney International [Elsevier BV]
卷期号:82 (5): 570-580 被引量:102
标识
DOI:10.1038/ki.2012.136
摘要

KDOQI practice guidelines recommend predialysis blood pressure <140/90 mm Hg; however, most prior studies had found elevated mortality with low, not high, systolic blood pressure. This is possibly due to unmeasured confounders affecting systolic blood pressure and mortality. To lessen this bias, we analyzed 24,525 patients by Cox regression models adjusted for patient and facility characteristics. Compared with predialysis systolic blood pressure of 130-159 mm Hg, mortality was 13% higher in facilities with 20% more patients at systolic blood pressure of 110-129 mm Hg and 16% higher in facilities with 20% more patients at systolic blood pressure of ≥160 mm Hg. For patient-level systolic blood pressure, mortality was elevated at low (<130 mm Hg), not high (≥180 mm Hg), systolic blood pressure. For predialysis diastolic blood pressure, mortality was lowest at 60-99 mm Hg, a wide range implying less chance to improve outcomes. Higher mortality at systolic blood pressure of <130 mm Hg is consistent with prior studies and may be due to excessive blood pressure lowering during dialysis. The lowest risk facility systolic blood pressure of 130-159 mm Hg indicates this range may be optimal, but may have been influenced by unmeasured facility practices. While additional study is needed, our findings contrast with KDOQI blood pressure targets, and provide guidance on optimal blood pressure range in the absence of definitive clinical trial data.

科研通智能强力驱动
Strongly Powered by AbleSci AI
科研通是完全免费的文献互助平台,具备全网最快的应助速度,最高的求助完成率。 对每一个文献求助,科研通都将尽心尽力,给求助人一个满意的交代。
实时播报
刚刚
yydssss发布了新的文献求助10
1秒前
专一的白完成签到,获得积分10
2秒前
Hello应助HaoHao04采纳,获得10
3秒前
3秒前
今后应助momo采纳,获得10
4秒前
5秒前
壮壮发布了新的文献求助10
5秒前
moon发布了新的文献求助10
5秒前
Akim应助悲伤的小卷毛采纳,获得10
6秒前
英俊的铭应助搞怪城采纳,获得10
6秒前
王青文发布了新的文献求助10
6秒前
怡然的复天完成签到,获得积分10
9秒前
海绵小方块完成签到,获得积分10
9秒前
9秒前
静夜谧思发布了新的文献求助10
12秒前
13秒前
13秒前
研友_VZG7GZ应助18661763395采纳,获得10
13秒前
123完成签到,获得积分10
13秒前
端庄雁露发布了新的文献求助10
14秒前
shiyi0709发布了新的文献求助200
14秒前
研友_Ljqal8发布了新的文献求助20
15秒前
Ava应助安详念蕾采纳,获得10
16秒前
17秒前
17秒前
看云打哈欠完成签到,获得积分10
18秒前
19秒前
影子子子发布了新的文献求助10
20秒前
21秒前
21秒前
OK应助杨胖胖采纳,获得50
22秒前
22秒前
23秒前
23秒前
搞怪城发布了新的文献求助10
24秒前
Ava应助李瑶采纳,获得10
24秒前
有空发布了新的文献求助10
24秒前
Memory发布了新的文献求助10
25秒前
25秒前
高分求助中
(应助此贴封号)【重要!!请各用户(尤其是新用户)详细阅读】【科研通的精品贴汇总】 10000
Prompt Engineering for Clinicians: Harnessing AI in Everyday Medical Practice 600
Electrode Potentials 550
REAL-WORLD EFFICACY AND GENOMIC LANDSCAPE OF POLATUZUMA VEDOTIN-BASED FIRST-LINE THERAPY IN DIFFUSE LARGE B-CELL LYMPHOMA: A FOCUS ON TP53 MUTATIONS AND TREATMENT RESPONSE 500
Handbook of Luminescence Dating 500
Safety Pharmacology 500
《KNN基无铅压电陶瓷电学性能优化与物理机理研究》 500
热门求助领域 (近24小时)
化学 材料科学 医学 生物 纳米技术 工程类 有机化学 计算机科学 化学工程 生物化学 物理 内科学 复合材料 催化作用 光电子学 物理化学 电极 细胞生物学 基因 遗传学
热门帖子
关注 科研通微信公众号,转发送积分 6963121
求助须知:如何正确求助?哪些是违规求助? 8645234
关于积分的说明 18335410
捐赠科研通 6413186
什么是DOI,文献DOI怎么找? 3086646
关于科研通互助平台的介绍 2135812
邀请新用户注册赠送积分活动 2063091